Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients

Rheumatology International

Volumn 33, Issue 9, 2013, Pages 2283-2289

  El Hini, Sahar Hossam ^a   Mohamed, Faten Ismail ^a   Hassan, Amel Ali ^a   Ali, Fatma ^a   Mahmoud, Amel ^a   Ibraheem, Hanaa M ^a  

^a Minia University   (Egypt)

Author keywords

Metabolic disturbance; Rheumatoid patients; Visfatin

Indexed keywords

ADIPONECTIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RHEUMATOID FACTOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADIPONECTIN; ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; LOGISTIC MODELS; MALE; METABOLIC DISEASES; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

EID: 84883150219     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2714-3     Document Type: Article

References (44)

1. Dessein P, Joffe B, Singh S (2005) Biomarkers of endothelial dysfunction cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7(3):634-643
2. Dessein PH, Joffe BI (2006) Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 54(9):2765-2775
3. Doran M (2007) Rheumatoid arthritis and diabetes mellitus: evidence for an association? J Rheumatol 34:460-462
4. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC, Lenfant C (2004) Definition of metabolic syndrome report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 109:433-438
5. Targońska-Stȩpniak B, Dryglewska M, Majdan M (2009) Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. Rheumatol Int Clin Exp Investig. doi: 10.1007/s00296-009-1053
6. Toussirot É, Streit G, Wendling D (2007) The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 14:1095-1100
7. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430
8. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ (2006) Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocr Metab 91:295-299
9. Nishida K, Okada Y, Nawata M, Saito K, Tanaka Y (2008) Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. Endocr J 55(1):213-216
10. Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ, Gualillo O (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65:1198-1201
11. Nagashima T, Okubo-Fornbacher H, Aoki Y, Kamata Y, Kimura H, Kamimura T, Nara H, Iwamoto M, Yoshio T, Okazaki H, Minota S (2008) Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis. J Rheumatol 35(5):936-938
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
13. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44-48
14. Gallagher D, Visser M, Sepulveda D, Pierson R, Harris T, Heymsfield SB (1996) How useful is body mass index for comparison of body fatness across age, sex and ethnic groups? Am J Epidemiol 143:228-239
15. Friedwald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
16. Nielen MM, van Schaardenburg D, Reesink HW et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380-386
17. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M (2002) HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25:1135-1141
18. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ et al (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52:402-411
19. van Halm VP, Nielen MMJ, Nurmohamed MT, van Schaardenburg D, Reesink HW, Voskuyl AE et al (2007) Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 66:184-188
20. Rall LC, Roubenoff R (2004) Rheumatoid cachexia, metabolic abnormalities, mechanisms and interventions. Rheumatology 43:1219-1223
21. Cantaert T, De Rycke L, Bongartz T, Nichola AP, Matteson EL (2006) Citrullinated proteins in rheumatoid arthritis. Arthritis Rheum 60:1356-1400
22. Niewold TB, Harrison MJ, Paget SA (2007) Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. QJM 100(4):193-201
23. Dessein PH, Stanwix AE, Joffe BI (2002) Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 4:R5
24. Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how "high grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108:2957-2963
25. Escárcega RO, García-Carrasco M, Fuentes-Alexandro S, Jara LJ, Rojas-Rodriguez J, Escobar-Linares LE et al (2006) Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus- related coronary disease. Autoimmun Rev 6:48-53
26. Önde ME, Top C, Öncül O (2008) The correlation of insulin resistance with serum tumor necrosis factor-alpha levels in patients with rheumatoid arthritis. Endocrinologist 18:178-181
27. Shahin D, Eltoraby E, Mesbah A, Houssen M (2010) Insulin resistance in early untreated rheumatoid arthritis patients. Clin Biochem 43(7):661-665
28. Karlson EW, Chibnik LB, Tworoger SS, Lee IM, Buring JE, Shadick NA et al (2009) Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum 60:641-652
29. van Halm VP, Nielen MMJ, Nurmohamed MT, van Schaardenburg D, Reesink HW, Voskuyl E et al (2007) Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 66:184-188
30. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ et al (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52:402-411
31. Burger D, Dayer JM (2002) High-density lipoprotein-associated apolipoprotein A-1: the missing link between infection and chronic inflammation? Autoimmun Rev 1:111-117
32. Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD et al (2006) Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study. Arthritis Res Ther 8:R 82
33. Georgiadis AN, Voulgari PV, Argyropoulou MI, Alamanos Y, Elisaf M, Tselepis AD et al (2008) Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. Semin Arthritis Rheum 38:13-19
34. Steiner G, Urowitz MB (2009) Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 38:372-381
35. Papa C, Netea MG, Radstake T, Van Der Meer JWM, Stalenhoef AFH (2005) Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis 64:303-305
36. La Montagna G, Cacciapuoti F, Buono R, Manzella D, Mennillo GA, Arciello A et al (2007) Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diabetes Vasc Dis Res 4:130-135
37. Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S64-S73
38. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, Marshall JC (2004) Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Investig 113:1318-1327
39. Alkady EA, Ahmed HM, Tag L, Abdou MA (2011) Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity. Z Rheumatol 70(7):602-608
40. Davutoglu M, Ozkaya M, Guler E, GaripardIc M, Gursoy H, Karabiber H, KIlInc M (2009) Plasma visfatin concentrations in childhood obesity: relationships to insulin resistance and anthropometric indices. Swiss Med Wkly 139(1-2):22-27
41. Zakaria S, Farouk G, El Saadany H, Mahmoud Selim H (2010) Changes in visfatin, adiponectin, leptin and ghrelin levels in patients with rheumatoid arthritis and their correlation with disease activity. Turk J Biochem 35(1):50-57
42. Rho YH, Solus J, Sokka T, Oeser ABS, Chung CP, Gebretsadik T, Shintani A, Pincus T, Stein CM (2009) Adipocytokines Are Associated with Radiographic Joint Damage in Rheumatoid Arthritis. Arthritis Rheum 60(7):1906-1914
43. Fantuzzi G (2008) Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 121:326-330
44. Lewicki M, Kotyla P, Kucharz E (2008) Etanercept increases adiponectin level in woman with rheumatoid arthritis. Clin Rheumatol 27:1337-1338